Metagenics

Vasotensin

D
N+ Score60
ProteinServing: 2 Tablet(s)Type: Amino acid/Protein

Vasotensin by Metagenics is classified as an 'Amino acid/Protein' supplement, featuring a concise total of 3 ingredients. This product holds an N+ Score of 60, earning a 'D' grade, indicating an average quality assessment. Its primary active component is Fish Protein powder, provided at 750mg per serving, with a modest 1 gram of protein and 10 calories per serving. The formula does not list any ingredients at clinically studied dosages, nor are any specifically identified as underdosed, suggesting a focused but potentially limited scope. With 100% label transparency, consumers have full insight into its composition. The ingredient adequacy and formula completeness scores are 50% and 33% respectively, reflecting its simple formulation. This product may be suitable for individuals seeking a specific fish protein supplement with a minimalist ingredient profile.

About This Product

Vasotensin by Metagenics is a protein supplement containing 3 active ingredients. It has earned an N+ Score of 60/100 (Grade D).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness33/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity72/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (3 ingredients)

IngredientAmountDose Adequacy
Calories10.000 Calorie(s)N/A
Protein1.000 Gram(s)N/A
Fish Protein powder750.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.